Skip to content
Image of the aircraft. Wide wings, single prop engine on the front. Short 2 seater cockpit.

Our legacy LEA UAS reborn.


Years of collective operational expertise,
including cost reduction manufacturing and modular functionality to further optimize ISR mission performance.

MARIANA delivers unmatched ISR mission performance at an optimal cost point, reimagined from TSC’s legacy long-endurance aircraft (LEA).  

TSC’s LEA systems are force multipliers designed to extend the reach of human awareness and accelerate decision-making where persistence, coverage, and resilience are mission critical.  With refined manufacturing, modular open architecture design for rapid mission reconfiguration, and next-generation technology, MARIANA is purpose-built to meet today’s most demanding operational requirements.

TSC teamed with Pipistrel, a leader in aerospace innovation, and AEVEX, experts in ISR integration, to deliver a more efficient Group 5, long-endurance, multi-INT platform that redefines lifecycle efficacy and operational value.  

Maximum Performance and Flexibility

Engineered for greater autonomy, versatility, and long-endurance ISR missions.

  • Autonomous take-off and landing
  • Nearly autonomous “point-click” operation
  • Redundant, modular open systems architecture
  • Optimized aerodynamics and structural upgrades over legacy LEA variants


Best Value Multi-INT Platform in its Class

MARIANA is the most cost-effective Group 5 UAS available, outperforming comparable platforms when evaluating capability vs. total system cost.

  • Flexible sensor and payload options
  • Redundant onboard networks and critical systems
  • Seamless integration of BLOS & LOS communications, IFF, PNT, and voice systems
  • Designed for multi-mission ISR operations across diverse environments

Mission Ready

MARIANA is the platform of choice for teams who demand affordable long-endurance ISR with proven performance, modular open architectures, and maximum operational efficiency.

Developed in Collaboration with Pipistrel and Aevex

Back To Top